Clinical pharmacokinetics of nifedipine gastrointestinal therapeutic system. A controlled-release formulation of nifedipine.
about
Comparison of 24-hour ambulatory blood pressure data in hypertensive patients switched from nifedipine-GITS to nifedipine-CC.Therapeutic Differences in 24-h Ambulatory Blood Pressures in Patients Switched Between Bioequivalent Nifedipine Osmotic Systems With Differing Delivery Technologies.Extended-release nifedipine bezoar identified one year after discontinuation.Review of the diagnosis and management of gastrointestinal bezoarsNifedipine Gastrointestinal Therapeutic System (GITS) in the treatment of coronary heart disease and hypertension.A Screen of Approved Drugs Identifies the Androgen Receptor Antagonist Flutamide and Its Pharmacologically Active Metabolite 2-Hydroxy-Flutamide as Heterotropic Activators of Cytochrome P450 3A In Vitro and In Vivo.Use of nifedipine in the treatment of hypertension.Clinical pharmacokinetics of doxazosin in a controlled-release gastrointestinal therapeutic system (GITS) formulation.Formulation of long-acting nifedipine tablets influences the heart rate and sympathetic nervous system response in hypertensive patients.Nifedipine gastrointestinal therapeutic system: an overview of its antiatherosclerotic effects.Long-acting nifedipine in the management of the hypertensive patient.Role of physiological intestinal water in oral absorption.Pharmacokinetics and pharmacodynamics of extended-release glipizide GITS compared with immediate-release glipizide in patients with type II diabetes mellitus.Impact of baseline blood pressure on the magnitude of blood pressure lowering by nifedipine gastrointestinal therapeutic system: refreshing the Wilder's principle.Dissolution and absorption modeling: model expansion to simulate the effects of precipitation, water absorption, longitudinally changing intestinal permeability, and controlled release on drug absorption.Arg347Cys polymorphism of alpha1A-adrenoceptor gene is associated with blood pressure response to nifedipine GITS in Chinese hypertensive patients.Development of novel spray coated soft elastic gelatin capsule sustained release formulations of nifedipine.Cross-over comparison of nifedipine Oros and felodipine extended release with blind 24 h ambulatory blood pressure assessments.
P2860
Q31920235-0221971B-9BE6-41D9-85C7-C9F83CCF7413Q33648055-6397AC89-3C82-45DE-8F7C-EDFA2DA4CFE4Q33992524-61C9EC42-BC91-4F48-B0F9-DC2CF3F7C808Q34473029-E7451283-8C7C-4927-95F1-868CAD56DD01Q34580796-C234EE7C-755B-4B6C-81B9-7838F32E40F9Q35743429-E9014D74-EE0F-4E5A-B1CF-CFC4421BD8FCQ36050471-72CEFF4A-408F-4535-BD88-4E8432B24AA2Q36053768-E46EA5F2-5831-402B-9516-EE17104A6BFDQ36729118-BB8BDDAE-DEAD-4AE4-9FBD-9A78E5443169Q36960568-146EADA5-875A-4387-804B-075982756B5BQ37145695-F4C658B1-355F-4FDD-B190-DF2AEAC75CB4Q43117344-1B456BF2-5608-443A-8044-A6869523F6C2Q44013969-AE8BBF3F-EB6E-4723-9B61-AFC11A2AEB11Q44498471-87ED6AC7-838F-4E20-9020-38A0E7FD24DBQ44626145-33BA391B-4788-40BB-8FCC-C4C6AC5F10ACQ45292671-2780617C-3AE6-4B76-8B37-7AE935D64578Q46093849-8A48507B-6A15-4D83-953C-917F4C85AB65Q53922190-B817635F-AEF3-4E71-BF1D-C15D811E95B7
P2860
Clinical pharmacokinetics of nifedipine gastrointestinal therapeutic system. A controlled-release formulation of nifedipine.
description
1987 nî lūn-bûn
@nan
1987 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Clinical pharmacokinetics of n ...... ase formulation of nifedipine.
@ast
Clinical pharmacokinetics of n ...... ase formulation of nifedipine.
@en
Clinical pharmacokinetics of n ...... ase formulation of nifedipine.
@nl
type
label
Clinical pharmacokinetics of n ...... ase formulation of nifedipine.
@ast
Clinical pharmacokinetics of n ...... ase formulation of nifedipine.
@en
Clinical pharmacokinetics of n ...... ase formulation of nifedipine.
@nl
prefLabel
Clinical pharmacokinetics of n ...... ase formulation of nifedipine.
@ast
Clinical pharmacokinetics of n ...... ase formulation of nifedipine.
@en
Clinical pharmacokinetics of n ...... ase formulation of nifedipine.
@nl
P2093
P1476
Clinical pharmacokinetics of n ...... ase formulation of nifedipine.
@en
P2093
P356
10.1016/0002-9343(87)90630-9
P407
P577
1987-12-01T00:00:00Z